Fangrun Medical Integrated Resources Acquires Meide Medical: Received Medtronic B-Leader
According to the latest news, Fangrun Medical Devices (Shanghai) Co., Ltd. (hereinafter referred to as “Fangrun Medicalâ€) announced the successful completion of the acquisition of Meide Medical Technology (Shanghai) Co., Ltd. (hereinafter referred to as “Mide Medicalâ€). Run Medical received the B round of investment from Medtronic China Fund, and the A-round investor, Sequoia Capital China Fund and WuXi PharmaTech, continued to follow the investment. Previously, the round A financing was 60 million yuan.
Mr. Qin Jie, the founder of the company, said that ablation technology is the most widely used and most used technology in the field of minimally invasive surgery. After years of hard work, the domestically produced ablation products have gradually matured in the field of cancer and other fields, gradually replacing imports, bringing good news to domestic cancer patients. Plasma ablation technology is a new generation of ablation technology developed in recent years. Its low temperature characteristics make it particularly advantageous in the application of joints, spine and ENT, and become the gold standard for minimally invasive surgery in sports medicine. With the aging of the global population and the lifestyle of healthy sports, sports medicine has gradually become a mainstream medical subject with huge social needs.
Fangrun Medical has obtained 5 CFDA registrations, 10 national patents, Shanghai high-tech enterprises, and obtained TUV product certification and ISO 13485 quality system certification. Many research products have undertaken major scientific research such as the Ministry of Science and Technology and the Science and Technology Support Program. Project; Since its establishment in 2009, with the improvement of research and development level and the change of production technology, the company's products involve sports medicine, spine, ENT and other fields. The company has gathered professional talents in machinery, electronics, polymer, precision processing, clinical medicine, etc., and has a group of experienced talents in product design, quality control, clinical verification, market development. At present, Fangrun Medical's low-temperature plasma minimally invasive treatment technology is at the international advanced level, and has participated in the drafting and formulation of domestic plasma industry standards.
The company's low-temperature plasma RF technology uses ultra-low-frequency electric energy excitation medium (Nacl) to generate plasma. The kinetic energy generated by the plasma breaks the molecular bond in the temperature range of 40-70 °C, and directly decomposes the biomolecule into O2, CO2. Gas such as N2 completes the functions of vaporization, ablation, shrinkage and hemostasis of soft tissues in a minimally invasive manner. The products are mainly used in arthroscopic surgery such as knee joint, shoulder joint, hip joint and facet joint, and ENT surgery. Tonsillectomy, adenoidectomy, soft palate drilling, tongue root drilling and uvulopalatopharyngoplasty, chronic hypertrophic rhinitis, vasomotor rhinitis, nasal congestion symptoms of allergic rhinitis, and minimally invasive treatment of spinal disc herniation .
Highlighter,Highlighter Makeup,Liquid Highlighter,Face Highlighter
Guangzhou Lingxue Cosmetics Co., Ltd , https://www.gzlxgj188.com